When to implement a commercial patient access programme


Dane Hartung
08/29/2017

Dane Hartung, Director Marketing and Access, Fougera Pharmaceuticals shares best practices for determining if and when you should implement a new Commercial Patient Access Program. Dane also discusses how you should go about ensuring your patient access program is ethical, compliant and effectively differentiates your product.

[inlinead] 

Dane will be presenting at the Pre-Approval Access Programs this September 25-27th in Philadelphia, PA. 

Download the article via the button below